KG501, a CREB inhibitor, reversed DKK1 expression in myeloma cells exposed to hypoxia (Fig. 2f), and CREB overexpression upregulated DKK1 in myeloma cells (Fig. 2g). This evidence concerns the gene CREB1 and plasma cell myeloma.